Microsoft
MSFT
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Apple
AAPL
US Stock MarketDetailed Quotes
COEP Coeptis Therapeutics
- 0.190
- +0.005+2.93%
Trading Dec 12 10:54 ET
7.81MMarket Cap-0.68P/E (TTM)
0.200High0.179Low1.11MVolume0.200Open0.185Pre Close206.01KTurnover3.37%Turnover RatioLossP/E (Static)41.12MShares0.97052wk High1.62P/B6.28MFloat Cap0.15152wk Low--Dividend TTM33.04MShs Float21.420Historical High--Div YieldTTM11.32%Amplitude0.151Historical Low0.185Avg Price1Lot Size
About Coeptis Therapeutics Company
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
Company Profile
SymbolCOEP
Company NameCoeptis Therapeutics
Listing DateDec 17, 2020
Founded2017
CEOMr. David Mehalick
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address105 Bradford Road,Suite 420
CityWexford
ProvincePennsylvania
CountryUnited States of America
Zip Code15090
Phone1-724-934-6467
Websitehttp://www.coeptistx.com
Company Executives
- Name
- Position
- Salary
- David Mehalick
- Chairman of the Board, President and Chief Executive Officer
- 18.33K
- Dr. Colleen Delaney, M.D.
- Chief Scientific and Medical Officer
- 360.00K
- Brian Cogley
- Chief Financial Officer
- 208.00K
- Christine Sheehy
- Vice President, Compliance and Corporate Secretary
- 151.00K
- Daniel Yerace
- Director and Vice President, Operations
- 18.33K
- Christopher Calise
- Director
- 18.33K
- Dr. Tara Maria DeSilva
- Independent Director
- 18.33K
- Dr. Gene Salkind, M.D.
- Independent Director
- 18.33K
- Christopher Cochran
- Independent Director
- 18.33K
- Philippe Deschamps
- Independent Director
- 18.33K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.